Corroborating the observations in BC patients, IL-6 serum levels are higher compared to healthy controls also in lung [53], bladder [54], ovarian [55], head and neck [56], and prostate cancer [57], and in all cases the IL-6 serum level is associated with worse prognosis. Here, IL6 is linked to prostate carcinoma.